ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

47 hedge funds and large institutions have $11.8M invested in Acorda Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$226K
Puts
$102K
Net Calls
Net Calls Change

Top Buyers

1
+$171K
2
+$149K
3
+$134K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$103K
5
Group One Trading
Group One Trading
Illinois
+$81K

Top Sellers

1
-$829K
2
-$756K
3
-$719K
4
GCP
GSA Capital Partners
United Kingdom
-$346K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$222K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$18K
27
$17K
28
$17K
29
$15K
30
$12K
31
$11K
32
$10K
33
$9K
34
$9K
35
$9K
36
$8K
37
$7K
38
$4K
39
$2K
40
$1K
41
$1K
42
$1K
43
$1K
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3